{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:00:07Z","timestamp":1790092807823,"version":"4.0.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["R61MH111935"],"award-info":[{"award-number":["R61MH111935"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["R61MH111935"],"award-info":[{"award-number":["R61MH111935"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol."],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1038\/s41386-026-02502-2","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T18:03:39Z","timestamp":1784225019000},"page":"2141-2151","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dose-related reductions in prefrontal recruitment during cognitive reappraisal following oral delta-9-tetrahydrocannabinol in posttraumatic stress disorder"],"prefix":"10.1038","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6678-0570","authenticated-orcid":false,"given":"Connor. J.","family":"Haggarty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9810-4024","authenticated-orcid":false,"given":"Christine. A.","family":"Rabinak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"key":"2502_CR1","unstructured":"Mann SK, Marwaha R, Torrico TJ. Posttraumatic stress disorder. In StatPearls (StatPearls Publishing, Treasure Island (FL), 2025)."},{"key":"2502_CR2","first-page":"273","volume":"107","author":"Z Sartor","year":"2023","unstructured":"Sartor Z, Kelley L, Laschober R. Posttraumatic stress disorder: evaluation and treatment. Am Fam Physician. 2023;107:273\u201381.","journal-title":"Am Fam Physician"},{"key":"2502_CR3","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/7854_2022_366","volume":"56","author":"AJ Khan","year":"2022","unstructured":"Khan AJ, Bradley E, O\u2019Donovan A, Woolley J. Psilocybin for trauma-related disorders. Curr Top Behav Neurosci. 2022;56:319\u201332.","journal-title":"Curr Top Behav Neurosci"},{"key":"2502_CR4","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.biopsych.2021.07.019","volume":"91","author":"LM Mayo","year":"2022","unstructured":"Mayo LM, Rabinak CA, Hill MN, Heilig M. Targeting the endocannabinoid system in the treatment of posttraumatic stress disorder: a promising case of preclinicalclinical translation? Biol Psychiatry. 2022;91:262\u201372.","journal-title":"Biol Psychiatry"},{"key":"2502_CR5","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1038\/s41591-023-02565-4","volume":"29","author":"JM Mitchell","year":"2023","unstructured":"Mitchell JM, Ot\u2019alora GM, van der Kolk B, Shannon S, Bogenschutz M, Gelfand Y, et al. MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial. Nat Med. 2023;29:2473\u201380.","journal-title":"Nat Med"},{"key":"2502_CR6","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1080\/17512433.2023.2276309","volume":"16","author":"LJ Ney","year":"2023","unstructured":"Ney LJ, et al. Challenges and considerations for treating PTSD with medicinal cannabis: the Australian clinician\u2019s perspective. Expert Rev Clin Pharm. 2023;16:1093\u2013108.","journal-title":"Expert Rev Clin Pharm"},{"key":"2502_CR7","first-page":"525","volume":"55","author":"L Orsolini","year":"2019","unstructured":"Orsolini L, Chiappini S, Volpe U, De Berardis D, Latini R, Papanti GD, et al. Use of medicinal cannabis and synthetic cannabinoids in post-traumatic stress disorder (PTSD): a systematic review. Med (Mex). 2019;55:525.","journal-title":"Med (Mex)"},{"key":"2502_CR8","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/YCO.0000000000000562","volume":"33","author":"VL Chadwick","year":"2020","unstructured":"Chadwick VL, Rohleder C, Koethe D, Leweke FM. Cannabinoids and the endocannabinoid system in anxiety, depression, and dysregulation of emotion in humans. Curr Opin Psychiatry. 2020;33:20\u201342.","journal-title":"Curr Opin Psychiatry"},{"key":"2502_CR9","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1038\/npp.2015.359","volume":"41","author":"SM Gorka","year":"2016","unstructured":"Gorka SM, Phan KL, Lyons M, Mori S, Angstadt M, Rabinak CA. Cannabinoid modulation of frontolimbic activation and connectivity during volitional regulation of negative affect. Neuropsychopharmacol Publ Am Coll Neuropsychopharmacol. 2016;41:1888\u201396.","journal-title":"Neuropsychopharmacol Publ Am Coll Neuropsychopharmacol"},{"key":"2502_CR10","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.ejphar.2018.07.039","volume":"834","author":"V Micale","year":"2018","unstructured":"Micale V, Drago F. Endocannabinoid system, stress and HPA axis. Eur J Pharm. 2018;834:230\u20139.","journal-title":"Eur J Pharm"},{"key":"2502_CR11","doi-asserted-by":"publisher","first-page":"109222","DOI":"10.1016\/j.neuropharm.2022.109222","volume":"218","author":"R Pacitto","year":"2022","unstructured":"Pacitto R, Peters C, Iadipaolo A, Rabinak CA. Cannabinoid modulation of brain activation during volitional regulation of negative affect in trauma-exposed adults. Neuropharmacology. 2022;218:109222.","journal-title":"Neuropharmacology."},{"key":"2502_CR12","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.nlm.2013.09.009","volume":"113","author":"CA Rabinak","year":"2014","unstructured":"Rabinak CA, Angstadt M, Lyons M, Mori S, Milad MR, Liberzon I, et al. Cannabinoid modulation of prefrontal-limbic activation during fear extinction learning and recall in humans. Neurobiol Learn Mem. 2014;113:125\u201334.","journal-title":"Neurobiol Learn Mem"},{"key":"2502_CR13","doi-asserted-by":"publisher","first-page":"107758","DOI":"10.1016\/j.nlm.2023.107758","volume":"201","author":"NL Zabik","year":"2023","unstructured":"Zabik NL, Rabinak CA, Peters CA, Iadipaolo A. Cannabinoid modulation of corticolimbic activation during extinction learning and fear renewal in adults with posttraumatic stress disorder. Neurobiol Learn Mem. 2023;201:107758.","journal-title":"Neurobiol Learn Mem"},{"key":"2502_CR14","first-page":"435","volume":"72","author":"D Zhou","year":"2017","unstructured":"Zhou D, Li Y, Tian T, Quan W, Wang L, Shao Q, et al. Role of the endocannabinoid system in the formation and development of depression. Pharm. 2017;72:435\u20139.","journal-title":"Pharm"},{"key":"2502_CR15","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/npp.2017.162","volume":"43","author":"MN Hill","year":"2018","unstructured":"Hill MN, Campolongo P, Yehuda R, Patel S. Integrating endocannabinoid signaling and cannabinoids into the biology and treatment of posttraumatic stress disorder. Neuropsychopharmacology. 2018;43:80\u2013102.","journal-title":"Neuropsychopharmacology."},{"key":"2502_CR16","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1080\/10615800802179860","volume":"22","author":"A Eftekhari","year":"2009","unstructured":"Eftekhari A, Zoellner LA, Vigil SA. Patterns of emotion regulation and psychopathology. Anxiety Stress Coping. 2009;22:571\u201386.","journal-title":"Anxiety Stress Coping"},{"key":"2502_CR17","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.copsyc.2016.10.006","volume":"14","author":"CP McLean","year":"2017","unstructured":"McLean CP, Foa EB. Emotions and emotion regulation in posttraumatic stress disorder. Curr Opin Psychol. 2017;14:72\u201377.","journal-title":"Curr Opin Psychol"},{"key":"2502_CR18","first-page":"345","volume":"87","author":"N Kohn","year":"2014","unstructured":"Kohn N, Eickhoff SB, Scheller M, Laird AR, Fox PT, Habel U. Neural network of cognitive emotion regulation-an ALE meta-analysis and MACM analysis. Neuro-Image. 2014;87:345\u201355.","journal-title":"Neuro-Image"},{"key":"2502_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/2045-5380-2-9","volume":"2","author":"JP Hayes","year":"2012","unstructured":"Hayes JP, Hayes SM, Mikedis AM. Quantitative meta-analysis of neural activity in posttraumatic stress disorder. Biol Mood Anxiety Disord. 2012;2:9.","journal-title":"Biol Mood Anxiety Disord"},{"key":"2502_CR20","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1016\/j.neubiorev.2012.06.003","volume":"36","author":"R Patel","year":"2012","unstructured":"Patel R, Spreng RN, Shin LM, Girard TA. Neurocircuitry models of posttraumatic stress disorder and beyond: a meta-analysis of functional neuroimaging studies. Neurosci Biobehav Rev. 2012;36:2130\u201342.","journal-title":"Neurosci Biobehav Rev"},{"key":"2502_CR21","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1016\/j.psyneuen.2013.08.004","volume":"38","author":"MN Hill","year":"2013","unstructured":"Hill MN, Bierer LM, Makotkine I, Golier JA, Galea S, McEwen BS, et al. Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the world trade center attacks. Psychoneuroendocrinology. 2013;38:2952\u201361.","journal-title":"Psychoneuroendocrinology."},{"key":"2502_CR22","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1038\/mp.2013.61","volume":"18","author":"A Neumeister","year":"2013","unstructured":"Neumeister A, Normandin MD, Pietrzak RH, Piomelli D, Zheng MQ, Gujarro-Anton A, et al. Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study. Mol Psychiatry. 2013;18:1034\u201340.","journal-title":"Mol Psychiatry"},{"key":"2502_CR23","first-page":"2981","volume":"24","author":"JT Buhle","year":"2014","unstructured":"Buhle JT, Silvers JA, Wager TD, Lopez R, Onyemekwu C, Kober H, et al. Cognitive reappraisal of emotion: a meta-analysis of human neuroimaging studies. Cereb Cortex N Y N 1991. 2014;24:2981\u201390.","journal-title":"Cereb Cortex N Y N 1991"},{"key":"2502_CR24","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/hbm.23402","volume":"38","author":"AA Nicholson","year":"2017","unstructured":"Nicholson AA, Rabellino D, Densmore M, Frewen PA, Paret C, Kluetsch R, et al. The neurobiology of emotion regulation in posttraumatic stress disorder: Amygdala downregulation via real-time fMRI neurofeedback. Hum Brain Mapp. 2017;38:541\u201360.","journal-title":"Hum Brain Mapp"},{"key":"2502_CR25","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/HRP.0000000000000185","volume":"26","author":"JM Fitzgerald","year":"2018","unstructured":"Fitzgerald JM, DiGangi JA, Phan KL. Functional Neuroanatomy of Emotion and Its Regulation in PTSD. Harv Rev Psychiatry. 2018;26:116\u201328.","journal-title":"Harv Rev Psychiatry"},{"key":"2502_CR26","unstructured":"Weathers FW, Litz BT, Keane TM, Palmieri PA, Marx BP, Schnurr PP. The PTSD Checklist for DSM-5 (PCL-5). Scale available from the National Center for PTSD at www.ptsd.va.gov (2013)."},{"key":"2502_CR27","unstructured":"First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-patient Edition. (SCID-I\/NP) New York: Biometrics Research, New York State Psychiatric Institute, November 2002."},{"key":"2502_CR28","first-page":"34","volume":"59","author":"DV Sheehan","year":"1998","unstructured":"Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59:34\u201357.","journal-title":"J Clin Psychiatry"},{"key":"2502_CR29","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1037\/pas0000486","volume":"30","author":"FW Weathers","year":"2018","unstructured":"Weathers FW, Bovin MJ, Lee DJ, Sloan DM, Schnurr PP, Kaloupek DG, et al. The clinician-administered PTSD scale for DSM-5 (CAPS-5): Development and initial psychometric evaluation in military veterans. Psychol Assess. 2018;30:383\u201395.","journal-title":"Psychol Assess"},{"key":"2502_CR30","unstructured":"VA.gov | Veterans Affairs. https:\/\/www.ptsd.va.gov\/professional\/assessment\/adult-sr\/ptsd-checklist.asp."},{"key":"2502_CR31","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cct.2015.07.011","volume":"45","author":"Y Lin","year":"2015","unstructured":"Lin Y, Zhu M, Su Z. The pursuit of balance: An overview of covariate-adaptive randomization techniques in clinical trials. Contemp Clin Trials. 2015;45:21\u201325.","journal-title":"Contemp Clin Trials"},{"key":"2502_CR32","doi-asserted-by":"crossref","unstructured":"Issa MA, Narang S, Jamison RN, Michna E, Edwards RR, Penetar DM, et al. The subjective psychoactive effects of oral dronabinol studied in a randomized, controlled crossover clinical trial for pain. Clin J Pain. 2014;30:472\u20138.","DOI":"10.1097\/AJP.0000000000000022"},{"key":"2502_CR33","doi-asserted-by":"publisher","first-page":"327","DOI":"10.2165\/00003088-200342040-00003","volume":"42","author":"F Grotenhermen","year":"2003","unstructured":"Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet. 2003;42:327\u201360.","journal-title":"Clin Pharmacokinet"},{"key":"2502_CR34","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00213-002-1033-2","volume":"161","author":"SR Wachtel","year":"2002","unstructured":"Wachtel SR, ElSohly MA, Ross SA, Ambre J, de Wit H. Comparison of the subjective effects of Delta(9)-tetrahydrocannabinol and marijuana in humans. Psychopharmacol (Berl). 2002;161:331\u20139.","journal-title":"Psychopharmacol (Berl)"},{"key":"2502_CR35","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.1007\/s00213-019-05293-1","volume":"236","author":"S Babalonis","year":"2019","unstructured":"Babalonis S, Lofwall MR, Sloan PA, Nuzzo PA, Fanucchi LC, Walsh SL. Cannabinoid modulation of opioid analgesia and subjective drug effects in healthy humans. Psychopharmacol (Berl). 2019;236:3341\u201352.","journal-title":"Psychopharmacol (Berl)"},{"key":"2502_CR36","doi-asserted-by":"publisher","unstructured":"Aghaei AM, Spillane LU, Pittman B, Flynn LT, De Aquino JP, Nia AB, et al. Sex differences in the acute effects of oral THC: a randomized, placebo-controlled, crossover human laboratory study. medRxiv. 2024 2023.11.29.23299193. https:\/\/doi.org\/10.1101\/2023.11.29.23299193.","DOI":"10.1101\/2023.11.29.23299193"},{"key":"2502_CR37","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1001\/archgenpsychiatry.2008.519","volume":"66","author":"P Fusar-Poli","year":"2009","unstructured":"Fusar-Poli P, Crippa JA, Bhattacharyya S, Borgwardt SJ, Allen P, Martin-Santos R, et al. Distinct effects of \u03b49-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing. Arch Gen Psychiatry. 2009;66:95\u2013105.","journal-title":"Arch Gen Psychiatry"},{"key":"2502_CR38","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1037\/pha0000221","volume":"26","author":"M Colizzi","year":"2018","unstructured":"Colizzi M, McGuire P, Giampietro V, Williams S, Brammer M, Bhattacharyya S. Previous cannabis exposure modulates the acute effects of delta-9-tetrahydrocannabinol on attentional salience and fear processing. Exp Clin Psychopharmacol. 2018;26:582\u201398.","journal-title":"Exp Clin Psychopharmacol"},{"key":"2502_CR39","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/npp.2009.184","volume":"35","author":"S Bhattacharyya","year":"2010","unstructured":"Bhattacharyya S, Morrison PD, Fusar-Poli P, Martin-Santos R, Borgwardt S, Winton-Brown T, et al. Opposite effects of \u03b4-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology. Neuropsychopharmacology. 2010;35:764\u201374.","journal-title":"Neuropsychopharmacology."},{"key":"2502_CR40","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00213-012-2954-z","volume":"227","author":"ME Morean","year":"2013","unstructured":"Morean ME, de Wit H, King AC, Sofuoglu M, Rueger SY, O\u2019Malley SS. The drug effects questionnaire: psychometric support across three drug types. Psychopharmacol Berl. 2013;227:177\u201392.","journal-title":"Psychopharmacol Berl"},{"key":"2502_CR41","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1162\/089892902760807212","volume":"14","author":"KN Ochsner","year":"2002","unstructured":"Ochsner KN, Bunge SA, Gross JJ, Gabrieli JDE. Rethinking feelings: an FMRI study of the cognitive regulation of emotion. J Cogn Neurosci. 2002;14:1215\u201329.","journal-title":"J Cogn Neurosci"},{"key":"2502_CR42","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.biopsych.2004.10.030","volume":"57","author":"KL Phan","year":"2005","unstructured":"Phan KL, Fitzgerald DA, Nathan PJ, Moore GJ, Uhde TW, Tancer ME. Neural substrates for voluntary suppression of negative affect: A functional magnetic resonance imaging study. Biol Psychiatry. 2005;57:210\u20139.","journal-title":"Biol Psychiatry"},{"key":"2502_CR43","doi-asserted-by":"crossref","unstructured":"Bradley MM, Lang PJ. The International Affective Picture System (IAPS) in the study of emotion and attention. In Handbook of emotion elicitation and assessment. 29\u201346 (Oxford University Press, New York, NY, US, 2007).","DOI":"10.1093\/oso\/9780195169157.003.0003"},{"key":"2502_CR44","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1006\/nimg.1995.1023","volume":"2","author":"KJ Worsley","year":"1995","unstructured":"Worsley KJ, Friston KJ. Analysis of fMRI time-series revisited\u2014again. NeuroImage. 1995;2:173\u201381.","journal-title":"NeuroImage."},{"key":"2502_CR45","unstructured":"Brett M, Anton J-L, Valabregue R, Poline J-B Region of interest analysis using an SPM toolbox. in vol. 16 (NeuroImage, 2002)."},{"key":"2502_CR46","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1038\/s41592-025-02763-7","volume":"22","author":"C Rorden","year":"2025","unstructured":"Rorden C. MRIcroGL: voxel-based visualization for neuroimaging. Nat Methods. 2025;22:1613\u20134.","journal-title":"Nat Methods"},{"key":"2502_CR47","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.pnpbp.2017.06.001","volume":"79","author":"M Pic\u00f3-P\u00e9rez","year":"2017","unstructured":"Pic\u00f3-P\u00e9rez M, Radua J, Steward T, Mench\u00f3n JM, Soriano-Mas C. Emotion regulation in mood and anxiety disorders: a meta-analysis of fMRI cognitive reappraisal studies. Prog Neuropsychopharmacol Biol Psychiatry. 2017;79:96\u2013104.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2502_CR48","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.neuroimage.2011.05.073","volume":"58","author":"EK Diekhof","year":"2011","unstructured":"Diekhof EK, Geier K, Falkai P, Gruber O. Fear is only as deep as the mind allows: a coordinate-based meta-analysis of neuroimaging studies on the regulation of negative affect. NeuroImage. 2011;58:275\u201385.","journal-title":"NeuroImage."},{"key":"2502_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v067.i01","volume":"67","author":"D Bates","year":"2015","unstructured":"Bates D, M\u00e4chler M, Bolker B, Walker S. Fitting linear mixed-effects models using lme4. J Stat Softw. 2015;67:1\u201348.","journal-title":"J Stat Softw"},{"key":"2502_CR50","unstructured":"Lenth, RV Emmeans Estimated Marginal Means, Aka Least-Squares Means. -References - Scientific Research Publishing. 2021 https:\/\/www.scirp.org\/reference\/referencespapers?referenceid-3437485."},{"issue":"May","key":"2502_CR51","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3758\/bf03193146","volume":"39","author":"F Faul","year":"2007","unstructured":"Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39:175\u201391. https:\/\/doi.org\/10.3758\/bf03193146.","journal-title":"Behav Res Methods"},{"key":"2502_CR52","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s41386-021-01155-7","volume":"47","author":"M Alexandra Kredlow","year":"2022","unstructured":"Alexandra Kredlow M, Fenster RJ, Laurent ES, Ressler KJ, Phelps EA. Prefrontal cortex, amygdala, and threat processing: implications for PTSD. Neuropsychopharmacology. 2022;47:247\u201359.","journal-title":"Neuropsychopharmacology."},{"key":"2502_CR53","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s12264-021-00793-7","volume":"38","author":"J Zheng","year":"2021","unstructured":"Zheng J, Liu N, Xu H. Pathway matters: prefrontal control of negative emotions via distinct downstream regions. Neurosci Bull. 2021;38:226\u20138.","journal-title":"Neurosci Bull"},{"key":"2502_CR54","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.biopsych.2014.02.014","volume":"77","author":"JC Motzkin","year":"2015","unstructured":"Motzkin JC, Philippi CL, Wolf RC, Baskaya MK, Koenigs M. Ventromedial prefrontal cortex is critical for the regulation of amygdala activity in humans. Biol Psychiatry. 2015;77:276\u201384.","journal-title":"Biol Psychiatry"},{"key":"2502_CR55","doi-asserted-by":"publisher","first-page":"13435","DOI":"10.1523\/JNEUROSCI.4287-13.2014","volume":"34","author":"SN Garfinkel","year":"2014","unstructured":"Garfinkel SN, Abelson JL, King AP, Sripada RK, Wang X, Gaines LM, et al. Impaired contextual modulation of memories in PTSD: an fMRI and psychophysiological study of extinction retention and fear renewal. J Neurosci. 2014;34:13435\u201343.","journal-title":"J Neurosci"},{"key":"2502_CR56","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s11065-019-09398-4","volume":"29","author":"DG Andrewes","year":"2019","unstructured":"Andrewes DG, Jenkins LM. The role of the amygdala and the ventromedial prefrontal cortex in emotional regulation: implications for post-traumatic stress disorder. Neuropsychol Rev. 2019;29:220\u201343.","journal-title":"Neuropsychol Rev"},{"key":"2502_CR57","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/j.euroneuro.2013.06.009","volume":"23","author":"MG Bossong","year":"2013","unstructured":"Bossong MG, van Hell HH, Jager G, Kahn RS, Ramsey NF, Jansma JM. The endocannabinoid system and emotional processing: a pharmacological fMRI study with \u03949-tetrahydrocannabinol. Eur Neuropsychopharmacol. 2013;23:1687\u201397.","journal-title":"Eur Neuropsychopharmacol"},{"key":"2502_CR58","doi-asserted-by":"publisher","first-page":"4270","DOI":"10.1002\/hbm.23671","volume":"38","author":"K Zimmermann","year":"2017","unstructured":"Zimmermann K, Walz C, Derckx RT, Kendrick KM, Weber B, Dore B, et al. Emotion regulation deficits in regular marijuana users. Hum Brain Mapp. 2017;38:4270\u20139.","journal-title":"Hum Brain Mapp"},{"key":"2502_CR59","first-page":"42","volume":"74","author":"LE Klumpers","year":"2012","unstructured":"Klumpers LE, Beumer TL, van Hasselt JGC, Lipplaa A, Karger LB, Kleinloog HD, et al. Novel \u03949-tetrahydrocannabinol formulation Namisol\u00ae has beneficial pharmacokinetics and promising pharmacodynamic effects. Br. J Clin Pharm. 2012;74:42\u201353.","journal-title":"J Clin Pharm"},{"key":"2502_CR60","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1373\/clinchem.2010.152439","volume":"57","author":"EL Karschner","year":"2011","unstructured":"Karschner EL, Darwin WD, Goodwin RS, Wright S, Huestis MA. Plasma cannabinoid pharmacokinetics following controlled oral \u03b49-tetrahydrocannabinol and oromucosal cannabis extract administration. Clin Chem. 2011;57:66\u201375.","journal-title":"Clin Chem"},{"key":"2502_CR61","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00213-002-1169-0","volume":"164","author":"VH Curran","year":"2002","unstructured":"Curran VH, Brignell C, Fletcher S, Middleton P, Henry J. Cognitive and subjective dose-response effects of acute oral \u03949-tetrahydrocannabinol (THC) in infrequent cannabis users. Psychopharmacol (Berl). 2002;164:61\u201370.","journal-title":"Psychopharmacol (Berl)"},{"key":"2502_CR62","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1523\/JNEUROSCI.5603-07.2008","volume":"28","author":"KL Phan","year":"2008","unstructured":"Phan KL, Angstadt M, Golden J, Onyewuenyi I, Popovska A, de Wit H. Cannabinoid modulation of amygdala reactivity to social signals of threat in humans. J Neurosci J Soc Neurosci. 2008;28:2313\u20139.","journal-title":"J Neurosci J Soc Neurosci"},{"key":"2502_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-14203-4","volume":"7","author":"S Bhattacharyya","year":"2017","unstructured":"Bhattacharyya S, Egerton A, Kim E, Rosso L, Riano Barros D, Hammers A, et al. Acute induction of anxiety in humans by delta-9-tetrahydrocannabinol related to amygdalar cannabinoid-1 (CB1) receptors. Sci Rep. 2017;7:15025.","journal-title":"Sci Rep"},{"key":"2502_CR64","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1017\/S1461145709990617","volume":"13","author":"P Fusar-Poli","year":"2010","unstructured":"Fusar-Poli P, Allen P, Bhattacharyya S, Crippa JA, Mechelli A, Borgwardt S, et al. Modulation of effective connectivity during emotional processing by \u03949-tetrahydrocannabinol and cannabidiol. Int J Neuropsychopharmacol. 2010;13:421\u201332.","journal-title":"Int J Neuropsychopharmacol"},{"key":"2502_CR65","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/npp.2011.227","volume":"37","author":"JG Vaidya","year":"2012","unstructured":"Vaidya JG, Block RI, O\u2019Leary DS, Ponto LB, Ghoneim MM, Bechara A. Effects of chronic marijuana use on brain activity during monetary decision-making. Neuropsychopharmacology. 2012;37:618\u201329.","journal-title":"Neuropsychopharmacology."},{"key":"2502_CR66","doi-asserted-by":"publisher","first-page":"104801","DOI":"10.1016\/j.neubiorev.2022.104801","volume":"140","author":"B Gunasekera","year":"2022","unstructured":"Gunasekera B, Davies C, Blest-Hopley G, Veronese M, Ramsey NF, Bossong MG, et al. Task-independent acute effects of delta-9-tetrahydrocannabinol on human brain function and its relationship with cannabinoid receptor gene expression: a neuroimaging meta-regression analysis. Neurosci Biobehav Rev. 2022;140:104801.","journal-title":"Neurosci Biobehav Rev"},{"key":"2502_CR67","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1038\/npp.2012.123","volume":"37","author":"AA Rey","year":"2012","unstructured":"Rey AA, Purrio M, Viveros M-P, Lutz B. Biphasic effects of cannabinoids in anxiety responses: CB1 and GABAB receptors in the balance of GABAergic and glutamatergic neurotransmission. Neuropsychopharmacology. 2012;37:2624\u201334.","journal-title":"Neuropsychopharmacology."},{"key":"2502_CR68","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-024-06702-w","author":"NL Zabik","year":"2024","unstructured":"Zabik NL, Iadipaolo A, Peters CA, Baglot SL, Hill MN, Rabinak CA. Dose-dependent effect of acute THC on extinction memory recall and fear renewal: a randomized, double-blind, placebo-controlled study. Psychopharmacology (Berl). 2024. https:\/\/doi.org\/10.1007\/s00213-024-06702-w.","journal-title":"Psychopharmacology (Berl)"},{"key":"2502_CR69","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1017\/S0033291720001129","volume":"51","author":"RA Bryant","year":"2021","unstructured":"Bryant RA, Erlinger M, Felmingham K, Klimova A, Williams LM, Malhi G, et al. Reappraisal-related neural predictors of treatment response to cognitive behavior therapy for post-traumatic stress disorder. Psychol Med. 2021;51:2454\u201364.","journal-title":"Psychol Med"},{"key":"2502_CR70","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1080\/08995605.2023.2250709","volume":"36","author":"JM Osgood","year":"2024","unstructured":"Osgood JM, Yates HK, Holzinger JB, Quartana PJ. Cognitive reappraisal moderates the effect of combat or other exposures on negative behavioral health symptoms. Mil Psychol. 2024;36:661\u2013671. https:\/\/doi.org\/10.1080\/08995605.2023.2250709.","journal-title":"Mil Psychol"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41386-026-02502-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-026-02502-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-026-02502-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T15:04:32Z","timestamp":1790089472000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41386-026-02502-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":70,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["2502"],"URL":"https:\/\/doi.org\/10.1038\/s41386-026-02502-2","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"assertion":[{"value":"17 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}